We used summary statistics from large genome-wide metanalyses—32,965 bone mineral density, 140,306 prostate cancer and 184,305 coronary artery disease subjects—to evaluate whether the lactase persistence allele was associated with these disease phenotypes. This evidence concerns the gene LCT and prostate cancer.